Controlling cancer chemotherapy-induced emesis
- 1 October 1991
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 13 (5) , 189-197
- https://doi.org/10.1007/bf01988874
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Comparison of the 5-Hydroxytryptamine3(Serotonin) Antagonist Ondansetron (Gr 38032F) with High-Dose Metoclopramide in the Control of Cisplatin-Induced EmesisNew England Journal of Medicine, 1990
- Oral Metoclopramide With or Without Diphenhydramine: Potential for Prevention of Late Nausea and Vomiting Induced by CisplatinJNCI Journal of the National Cancer Institute, 1988
- Pharmacokinetics of High-Dose Metoclopramide in Cancer PatientsClinical Pharmacokinetics, 1986
- Maintenance of Antiemetic Effect of a Metoclopramide-Dexamethasone Combination during Subsequent Cisplatin CoursesOncology, 1986
- Antiemetic Efficacy of DexamethasoneNew England Journal of Medicine, 1984
- On the receiving end—patient perception of the side-effects of cancer chemotherapyEuropean Journal of Cancer and Clinical Oncology, 1983
- The Pharmacology and Clinical Effectiveness of Phenothiazines and Related Drugs for Managing Chemotherapy-induced EmesisDrugs, 1983
- The Gastrointestinal Tract in Chemotherapy-induced EmesisDrugs, 1983
- Nausea and Vomiting as Major Complications of Cancer ChemotherapyDrugs, 1983
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981